Figure 2
Figure 2. Longitudinal analysis of CD8 naive and memory T-cell subpopulation reconstitution in +CMV and −CMV patients. (A) Representative flow cytometry analysis of memory subset marker expression in CD8+ T cells. Cells were gated as follows: lymphocytes were identified by FSC and SSC, CD14−CD3+ T lymphocytes were identified, further distinguished into CD8+ and CD4+ T cells, and analyzed for their expression of CCR7 and CD45RA memory markers. Tnaive were identified as CCR7+/CD45RA+, TCM: CCR7+/CD45RA−, TEM: CCR7−/CD45RA−, TEMRA: CCR7−/CD45RA+. (B-C) Longitudinal analysis of CD8+ naive and Tem subsets depicted in percentage frequency (B) or absolute cell numbers (C). Data are mean ± SEM in +CMV patients (n = 7), −CMV patients (n = 10), and healthy controls (n = 10). Also shown is the mean day of CMV reactivation (±SEM), depicted as a purple bar. (D) Left, Representative flow cytometry analysis at day +365 shows CD28 expression (left panel) and Granzyme B expression (right panel) on CD8+ Tem. Right, Longitudinal analysis of mean ± SEM CD28−CD8+ Tem (left y-axis) and Granzyme B+CD8+ Tem (right y-axis). (E) Longitudinal analysis of PD-1−/CD57+CD8+ Tem (solid lines) and naive T cells (dotted lines) of +CMV (n = 7), −CMV (n = 10) patients, and healthy controls. All data are mean ± SEM. *P ≤ .05; **P ≤ .01 Wilcoxon rank-sum test. CCR, C-C chemokine receptor; FSC, forward scatter; SSC, side scatter; TCM, central memory T cells; TEMRA, effector memory-RA T cells.

Longitudinal analysis of CD8 naive and memory T-cell subpopulation reconstitution in +CMV and −CMV patients. (A) Representative flow cytometry analysis of memory subset marker expression in CD8+ T cells. Cells were gated as follows: lymphocytes were identified by FSC and SSC, CD14CD3+ T lymphocytes were identified, further distinguished into CD8+ and CD4+ T cells, and analyzed for their expression of CCR7 and CD45RA memory markers. Tnaive were identified as CCR7+/CD45RA+, TCM: CCR7+/CD45RA, TEM: CCR7/CD45RA, TEMRA: CCR7/CD45RA+. (B-C) Longitudinal analysis of CD8+ naive and Tem subsets depicted in percentage frequency (B) or absolute cell numbers (C). Data are mean ± SEM in +CMV patients (n = 7), −CMV patients (n = 10), and healthy controls (n = 10). Also shown is the mean day of CMV reactivation (±SEM), depicted as a purple bar. (D) Left, Representative flow cytometry analysis at day +365 shows CD28 expression (left panel) and Granzyme B expression (right panel) on CD8+ Tem. Right, Longitudinal analysis of mean ± SEM CD28CD8+ Tem (left y-axis) and Granzyme B+CD8+ Tem (right y-axis). (E) Longitudinal analysis of PD-1/CD57+CD8+ Tem (solid lines) and naive T cells (dotted lines) of +CMV (n = 7), −CMV (n = 10) patients, and healthy controls. All data are mean ± SEM. *P ≤ .05; **P ≤ .01 Wilcoxon rank-sum test. CCR, C-C chemokine receptor; FSC, forward scatter; SSC, side scatter; TCM, central memory T cells; TEMRA, effector memory-RA T cells.

Close Modal

or Create an Account

Close Modal
Close Modal